title: Still defining optimal primaquine therapy against relapse after 63 years of continuous use.
authors.affiliation: Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; The Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, United Kingdom. Electronic address: kbaird@eocru.org.
authors.forename: J Kevin
authors.initials: JK
authors.lastname: Baird
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D016780:Malaria, Vivax / Q000188:drug therapy*; D008297:Male; D041122:Plasmodium ovale / Q000187:drug effects*; D010966:Plasmodium vivax / Q000187:drug effects*; D011319:Primaquine / Q000008:administration & dosage*; D014195:Travel
chemical_list: D000962:Antimalarials; D011319:Primaquine